University Medical Center Hamburg-EppendorfGermany
Stefan Kluge is a Professor at the Department of Intensive Care within the University Medical Center Hamburg-Eppendorf . With over 150 publications in 2025-2024 alone, his work focuses on critical care medicine, sepsis, ARDS, and cardiogenic shock. His recent research explores ARDS impact on liver cirrhosis outcomes Hyperoxia effects in traumatic brain injury Biomarkers for cardiogenic shock prognosis Novel retrograde limb perfusion techniques during ECPR Dual-energy CT for body composition analysis He contributes extensively to German national guidelines for nosocomial pneumonia and participates in multi-center critical care trials. Stefan Kluge's collaborations span neuro-intensive care , cardiovascular research , and infection/immunity domains. His work integrates machine learning applications and medical informatics to improve ICU decision-making.
Mayo Clinic College of Medicine and ScienceUnited States
Virend Somers, M.D., Ph.D. , is a Professor of Medicine at Mayo Clinic in Rochester, Minnesota, with primary appointments in the Department of Cardiovascular Medicine, and joint appointments in Physiology & Biomedical Engineering and Nephrology & Hypertension. He directs the Cardiovascular and Sleep Facilities within Mayo Clinic's Center for Clinical and Translational Science. Education: MB ChB, University of Natal D.Phil., University of Oxford Resident, Internal Medicine, University of Iowa Fellow, Cardiovascular Diseases, University of Iowa Hospitals and Clinics Research Interests: Dr. Somers' research centers on neural and vascular mechanisms in circulatory control, particularly in sleep disorders such as obstructive and central sleep apnea, hypertension, obesity, and heart failure. His team investigates autonomic nervous system regulation, chemoreflex responses, and vascular biology in humans. His work bridges basic physiology with clinical applications to improve cardiovascular outcomes. Publication Trends: His recent publications (2021–2025) show a strong emphasis on sleep-cardiovascular interactions, including blood pressure regulation during sleep, cardiovascular mortality in the context of comorbidities like obesity and COVID-19, and neurocardiological mechanisms in arrhythmias and syncope. His work frequently appears in high-impact journals such as Sleep , Journal of the American Heart Association , and Journal of Physiology . Scientific Awards: Alice Sheets Marriott Professor (2016) CTSA Mentor of the Year (2012) Distinguished Scientist in Cardiopulmonary Physiology, American College of Chest Physicians (2017) Stanford University World's Top 2% Scientists (2021) Lifetime Achievement Award, South African Society of Sleep Medicine (2012) Doctor Honoris Causa, Masaryk University (2007) Advising and Grants: Dr. Somers has mentored numerous trainees who have won national awards. His research is supported by four NIH R01 grants, a Dana Foundation grant, and a NATO grant. His leadership in collaborative research spans institutions in the U.S., Europe, and South Africa. Labs and Teams: He leads the Cardiovascular Facility and Sleep Facility at Mayo Clinic’s Center for Clinical and Translational Science, fostering interdisciplinary research on sleep and cardiovascular disease.
Joe Stock is an Assistant Professor in Kinesiology at East Carolina University's College of Health and Human Performance. He operates the Human Performance Lab, focusing on cardiovascular wellness in aging and at-risk populations. B.S. in Exercise Science, Slippery Rock University M.S. in Health, Physical Activity and Chronic Disease, University of Pittsburgh Ph.D. in Kinesiology and Applied Physiology, University of Delaware His research examines aortic hemodynamics, vascular function, and lifestyle interventions through echocardiography, blood vessel ultrasound, and non-invasive blood pressure analysis. He explores sex differences in neurocardiovascular responses and salt sensitivity mechanisms. Recent publications demonstrate expertise in chronic kidney disease adaptations, exercise-induced vascular changes, and central sodium sensing. Collaborations span cardiovascular physiology, nephrology, and autonomic neuroscience. National Heart, Lung, and Blood Institute grant (2021-2023) University of Delaware Dissertation Fellowship (2019) University of Delaware Summer Doctoral Fellowship (2018) Professional service includes American Heart Association membership, ACSM regional committee work, and development of clinical exercise programs for renal patients. His work integrates applied physiology with translational medicine.
Mehmet Karahan is an Associate Professor in the Department of Cardiovascular Surgery at Gaziantep University Faculty of Medicine. He specializes in cardiovascular surgery with a focus on mechanical circulatory support, left ventricular assist devices (LVAD), heart transplantation, and endovascular procedures. His clinical and research work centers on innovative approaches to treating complex cardiac conditions. His educational background includes: Medical License (English Program): Hacettepe University Faculty of Medicine (2004-2011), Turkey Specialization in Cardiovascular Surgery: Health Sciences University, Ankara High Specialized Health Application and Research Center (2012-2017), Turkey Dr. Karahan's research interests span multiple areas within cardiovascular medicine. He has made significant contributions to the field of mechanical circulatory support, particularly focusing on left ventricular assist devices (LVAD) and their applications in both adult and pediatric patients. His work explores minimally invasive approaches to LVAD implantation, management of complications, and integration with other cardiac procedures. Additionally, he has expertise in endovascular aortic repair techniques, including complex cases involving traumatic injuries and challenging anatomies. His research also extends to heart transplantation, anticoagulation management, and thrombophilia in vascular disease. Analysis of Dr. Karahan's recent publications reveals a strong focus on advancing mechanical circulatory support technologies, particularly LVAD systems. His work addresses critical challenges in the field including pediatric applications, minimally invasive techniques, management of complications like pump thrombosis, and integration with other cardiac procedures. He has also made significant contributions to endovascular aortic repair, developing innovative techniques for complex cases. His research demonstrates a multidisciplinary approach that bridges surgical innovation with patient-centered outcomes. Dr. Karahan is an active member of several professional organizations: European Association for Cardio-Thoracic Surgery (EACTS) - Member since 2024 International Society for Heart and Lung Transplantation (ISHLT) - Member since 2023 National Association of Vascular and Endovascular Surgery - Member since 2020 Turkish Cardiovascular Surgery Association - Member since 2014 He has served as an editor for The Turkish Journal of Thoracic and Cardiovascular Surgery (2025). His clinical work involves complex cardiovascular procedures, with a particular emphasis on innovative approaches to mechanical circulatory support and endovascular interventions. Dr. Karahan has presented his research at numerous national and international conferences, contributing to the advancement of cardiovascular surgical techniques. His professional experience includes positions at Gaziantep University, Ankara Bilkent City Hospital, and Turkey High Specialization Hospital. He has also gained international experience through observer positions at Paracelsus Medical University-Nuremberg Clinic, Hannover Medical School, University of Geneva, and Harvard University.
Carine J.M. Doggen is a Full Professor in Health Technology & Services Research at the TechMed Centre, University of Twente. She also serves as Scientific Director at Rijnstate Hospital since October 2017. Her academic career includes previous positions as Senior Researcher at Leiden University Medical Center (2000-2009), University of Washington, Seattle (2002-2003), and Sanquin Blood Bank (2006-2009). Her research focuses on evaluating healthcare innovations, particularly technologies enabling the transition of care from hospitals to home settings. Dr. Doggen specializes in assessing the implementation, reliability, and effectiveness of new medical technologies including wearable sensors and remote monitoring systems. Her work examines measurement validity and incorporates perspectives from both healthcare providers and patients. Analysis of her recent publications reveals strong expertise in cardiovascular technology evaluation, digital health interventions, and quality of life assessment. Her research shows particular strength in randomized clinical trials of medical devices, health technology assessment methodologies, and post-COVID health outcomes research. Dr. Doggen has presented her work at numerous conferences, with recent oral presentations including 'Towards personalised medicine: the potential of intensive longitudinal data to assess the interplay of chronic diseases' (2024) and 'Prognostic markers for acute heart failure in Chronic Obstructive Pulmonary Disease' (2021). She has also contributed to media discussions about healthcare innovations through the Rijnstate Collegetour series.
Per Sigvald Bakke is a Professor at the University of Bergen's Faculty of Medicine, Department of Clinical Science, with extensive expertise in respiratory medicine. His research primarily focuses on Chronic Obstructive Pulmonary Disease (COPD), asthma, and related pulmonary conditions, with significant contributions to understanding disease mechanisms, clinical phenotyping, and epidemiology. Dr. Bakke's research interests span COPD phenotyping, asthma heterogeneity, genomics of respiratory diseases, pulmonary function testing, and clinical epidemiology. His work frequently involves large-scale cohort studies and international collaborations, particularly through the U-BIOPRED consortium. His research has significantly advanced understanding of COPD progression, exacerbation risk factors, and the relationship between respiratory diseases and systemic conditions like metabolic syndrome. His publication record demonstrates consistent contributions to respiratory medicine, with recent work focusing on multi-omics approaches to disease phenotyping, genetic determinants of lung function, and clinical management of COPD. His research often bridges basic science with clinical application, addressing critical questions in respiratory disease management and patient outcomes. Dr. Bakke has been instrumental in numerous international collaborative studies including the ECLIPSE cohort, U-BIOPRED, and various genome-wide association studies examining COPD and asthma. His work has contributed to clinical guidelines and improved understanding of respiratory disease mechanisms across diverse populations.
Mattias Brunström serves as Assistant Professor of Cardiology and Associate Professor of Epidemiology at Umeå University's Faculty of Medicine within the Department of Public Health and Clinical Medicine, Section of Cardiology. He is concurrently a resident physician at Norrlands University Hospital and holds leadership roles as chairman of Sweden's national hypertension working group and scientific secretary of the Swedish Society for Hypertension, Stroke and Vascular Medicine, with active participation in the European and International Societies of Hypertension. His academic foundation includes a 2018 PhD thesis examining blood pressure-lowering treatment effects across different blood pressure levels through systematic reviews and meta-analyses of randomized clinical trials. This doctoral work established his expertise in evidence-based cardiovascular therapeutics and epidemiological methodology. Dr. Brunström's research program centers on cardiovascular disease risk factors, with specialized focus on hypertension pathophysiology and aortic diseases. His group investigates how adolescent blood pressure levels predict future cardiovascular events, examining interactions with obesity, physical fitness, and diabetes to improve risk stratification. They also analyze differential effects of antihypertensive drug classes on cardiovascular outcomes and study risk factors for aortic dissection/rupture to optimize preventive surgical interventions. This work addresses critical gaps in managing the world's leading cause of death, where uncontrolled hypertension contributes to 10 million annual fatalities despite effective treatments. Analysis of his 2024-2025 publications reveals dominant themes in hypertension guideline development, treatment threshold controversies, and cardiovascular risk assessment. His work frequently challenges conventional approaches (e.g., questioning excessive treatment of 'elevated' blood pressure in elderly patients) while advancing evidence for lifestyle interventions and beta-blocker utility. Methodologically, his research leverages large cohort studies (including 1.4 million enlistee data), systematic reviews, and international collaborations through societies like ESH and ISH to translate epidemiological findings into clinical practice. Dr. Brunström leads multiple funded research initiatives including 'Remission of type 2 diabetes through eHealth' (2022-2028) and 'VIPviza' (2013-2027), directing a multidisciplinary team that bridges clinical cardiology, epidemiology, and public health. His advisory role extends to national guideline committees and international hypertension societies where he shapes clinical practice through evidence synthesis and position papers. Based at Norrlands University Hospital's Cardiology Section, his research group operates within Umeå University's strong cardiovascular research ecosystem, maintaining active collaborations with the Swedish National Diabetes Register and international consortia. Their work emphasizes real-world applicability, examining topics like bedtime dosing of antihypertensives and self-report diagnostic tools to overcome barriers in hypertension control where only 25% of affected individuals achieve target blood pressure levels.
Tamara Stojmenović is a faculty member at Singidunum University within the Faculty of Physical Culture and Management in Sports . She holds a Doctor of Medicine degree from the University of Belgrade (2003-2010), a Specialist in Sports Medicine from the University of Belgrade (2014-2017), and a PhD in Experimental and Applied Physiology with Sports Medicine from the University of Kragujevac (2011-2019). Her research focuses on Sports Medicine , Physiology , and Cardiorespiratory Fitness , particularly examining: Cardiovascular responses to exercise Post-COVID-19 physiological impacts on athletes Physical activity optimization through ventilatory threshold analysis Comparative physiological profiles across sports disciplines Recent trends in her publications include athlete cardiac health, strain-specific SARS-CoV-2 effects, and injury prevention in basketball players. Her work appears in journals like Journal of Clinical Medicine , Diagnostics , and Medicina (Kaunas) , covering topics from maximal oxygen consumption to sports injury epidemiology. Professional Contributions: Co-author of two textbooks: Corrective gymnastics and kinesitherapy in sports (2021) and Sports medicine - through questions and answers (2020) Presented at multiple conferences on topics including ACL rupture prevention and athlete overtraining Conducts applied research on sports performance, physical activity prescription, and injury rehabilitation
Eva Lindberg is a Professor at the Department of Medical Sciences , Uppsala University , specializing in Lung, Allergy, and Sleep Research . She has contributed extensively to understanding the interplay between sleep-related disorders and respiratory/cardiovascular health. Research Themes : Sleep apnea, COPD, asthma, cardiometabolic risks, population-based studies. Key Collaborations : RHINESSA, SCAPIS, MUSTACHE cohorts. Her 2025 publications focus on cardiovascular consequences of sleep apnea, proteomic associations in lung disease, and cancer risks linked to nocturnal breathing disorders. Earlier work (2024–2022) examines obesity, physical activity, and environmental factors in sleep and respiratory health. Eva Lindberg is actively involved in clinical trials for sleep apnea interventions, including behavioral medicine and device-based therapies. She emphasizes sex-specific differences in sleep disorder diagnosis and outcomes.
University of California, San FranciscoUnited States
Adam Olshen, PhD, MA is a Professor in the Department of Epidemiology & Biostatistics at the University of California, San Francisco School of Medicine. His research program bridges advanced statistical methodology with cancer genomics and clinical applications, focusing on developing computational approaches to analyze complex genomic data and understand cancer biology and patient outcomes. Dr. Olshen's research spans multiple critical areas in computational biology and cancer genomics. He is best known for developing the circular binary segmentation algorithm, a foundational method for analyzing DNA copy number data that has become standard in cancer genomics research. His work consistently applies sophisticated statistical models to address biological questions, particularly in cancer research where he examines tumor biology, treatment response mechanisms, and patient symptomatology. Recent work demonstrates expertise in multi-omic analyses, single-cell sequencing methodologies, and machine learning applications for understanding cancer stem cells, treatment resistance mechanisms, and symptom biology. His research has particular strength in translating complex genomic data into clinically relevant insights. Analysis of Dr. Olshen's recent publications reveals a strong focus on applying cutting-edge computational methods to understand cancer biology at increasingly granular levels. His work spans multiple cancer types including breast cancer, leukemia, prostate cancer, and others, with particular attention to genomic alterations, epigenetic changes, and their relationship to clinical outcomes. A notable trend is the application of advanced computational techniques to analyze single-cell and multi-omic data to uncover novel biological insights about cancer heterogeneity, progression, and symptom biology. His publications frequently appear in high-impact journals across computational biology, oncology, and clinical medicine. Dr. Olshen maintains an active collaborative research program across UCSF, working extensively with clinicians and basic scientists to apply sophisticated statistical methods to complex biological questions. His work has contributed significantly to the development of novel biomarkers, improved understanding of cancer biology, and better methods for analyzing genomic data in clinical contexts. He has been instrumental in numerous studies examining the relationship between genomic alterations and clinical outcomes, as well as the development of novel computational methods for genomic data analysis that have been widely adopted by the research community.
Mayo Clinic College of Medicine and ScienceUnited States
Jeffrey W. Britton, M.D. is a Professor of Neurology at Mayo Clinic in Rochester, Minnesota, serving as Chair of the Division of Epilepsy and Program Director of the Epilepsy Fellowship. His clinical and academic work is centered within the Department of Neurology at Mayo Clinic College of Medicine and Science, with expertise in EEG monitoring and autoimmune neurology. His educational trajectory includes a B.S. in Biology (with distinction) from the University of Iowa (1985), an M.D. from Carver College of Medicine (1989), neurology residency (1993), and Clinical Neurophysiology fellowship (EEG/Epilepsy) at Mayo Clinic (1999). Britton's research specializes in autoimmune epilepsies and encephalopathies , particularly LGI1 antibody encephalitis, alongside cardiopulmonary effects of seizures , neuromodulation therapies , and innovations in epilepsy diagnostics . His work integrates clinical neurophysiology with neurology education, frequently examining EEG applications in autoimmune contexts. Recent publications (2016-2025) reveal a pronounced focus on autoimmune epilepsy mechanisms and stereo-EEG safety. Key trends include multicenter analyses of antibody-mediated encephalitis outcomes, seizure-related fall risks, and neuromodulation techniques, reflecting his leadership in translating neuroimmunology research into clinical practice. Notable honors include: Fellowships in American Epilepsy Society (2016), American Academy of Neurology (2016), American Clinical Neurophysiology Society, and American Neurological Association (2012) Excellence in Teaching Awards from Mayo Medical School (2004, 2005) Henry Woltman Award (Mayo Graduate School of Medicine, 1993) Magna cum laude citation for educational exhibits (Radiological Society of North America, 2020) Britton has trained neurology residents and fellows for decades while co-founding the Epilepsy-Neuroradiology Collaborative Research Meeting (2013-present). His grant-related activity includes serving as Epilepsy Foundation Grant Reviewer since 2013, though specific funded projects aren't detailed. He leads the Autoimmune Epilepsy Diagnosis Task Force (International League Against Epilepsy) and co-founded Mayo Clinic's Epilepsy Fellowship program infrastructure. Current initiatives include the Resident and Fellow Committee (American Clinical Neurophysiology Society) and American Board of Clinical Neurophysiology leadership (President since 2018).
Dr. Nirupama Laroia is a Clinical Professor at the University of Rochester School of Medicine and Dentistry , affiliated with the Department of Pediatrics and specializing in Neonatology . Her clinical expertise spans neonatal resuscitation, cardiopulmonary physiology, and global neonatal survival. Education : M.B.B.S., Christian Medical College & Hospital (India), 1980 Fellowship, Neonatology, University of Rochester Medical Center, 1994–1996 Residency, Pediatrics, Medical College of Virginia, 1993–1994 Residency, Pediatrics, Banaras Hindu University (India), 1981–1984 Dr. Laroia's research focuses on neonatal seizures , hypoxic-ischemic injury , and neuroprotective strategies . She has explored auditory toxicity in jaundiced infants, oxygen saturation targets for preterm infants, and cultural factors affecting breastfeeding. Her work emphasizes translational outcomes, linking EEG monitoring to seizure prediction and evaluating donor milk benefits for preterm infants. Her recent publications highlight trends in neonatal neurology , respiratory care , and metabolic studies . Notable topics include bilirubin-induced auditory neuropathy, oxygen saturation thresholds in preterm infants, and heat loss prevention in neonates. Scientific Awards : Best Doctors in America , 2004 Strong Star , University of Rochester Medical Center, 2008 & 2013 2005 Nominee, Father Norton Award , Rochester General Hospital
Lars I Eriksson is a Professor and head of the section of Anesthesiology and Intensive Care at the Department of Physiology and Pharmacology, Karolinska Institutet. His research focuses on the neuroinflammatory and cognitive consequences of surgical trauma and critical illness, with particular emphasis on mechanisms linking systemic inflammation to long-term brain dysfunction. He leads the research group "The brain after surgery and trauma - neuroinflammation, cognitive impairment and dementia" , which investigates postoperative neurocognitive decline, dementia risk, and immune-brain interactions. Key funding sources include the Swedish Research Council (VR Medicine), The Brain Foundation, and the Alzheimer Foundation. Research Interests : Neuroinflammation following surgery/trauma Cognitive decline mechanisms in postoperative patients Immune-brain communication in critical illness Pharmacological prevention of postoperative dementia Clinical translation of experimental immunology findings Recent Work Trends focus on: Immune profiling in critical care survivors (e.g., NeuroCOVID studies) Biomarker development for cognitive outcomes Extracellular vesicle roles in postoperative brain injury Grants & Collaborations**: Active projects include: VR Medicine grant exploring surgery-induced neuroinflammation ALF Region Stockholm funding for translational studies European Society for Anesthesiology support for clinical trials Labs/Teams**: Directly supervises a multidisciplinary team including research engineers (Anette Ebberyd) and senior specialists (e.g., Marta Gómez Galán, Souren Mkrtchian). Collaborates extensively across departments at Karolinska Institutet and internationally.
Jill Zafar, MD, MBA, FASA, is an Associate Professor of Anesthesiology at the Yale School of Medicine and Clinical Chair of Anesthesiology at Bridgeport Hospital, Yale New Haven Health. She serves as Director of the Pre-Surgical Evaluation Center and focuses on perioperative medicine, preoperative optimization, and telehealth integration. Her leadership roles include Medical Director of Pre-Surgical Evaluation for Yale New Haven Health and liaison for the Committee on the Status of Women in Medicine (SWIM). Education & Training: MBA, University of Massachusetts, Amherst (2022) Chief Resident, Anesthesiology, University at Buffalo (2008) MD, SUNY at Buffalo School of Medicine (2004) BS, Biochemistry, State University of New York at Geneseo (1999) Research Interests: Dr. Zafar’s work centers on perioperative care optimization, including the use of cardiopulmonary exercise testing, telehealth, and standardized protocols to reduce preoperative risks and environmental footprints. Her research also addresses challenges in managing high-risk surgical patients, such as those with idiopathic pulmonary fibrosis or hypertension. Publications Overview: Her recent work emphasizes the clinical utility of submaximal exercise testing in predicting postoperative complications and the efficiency gains of telehealth in bariatric surgery evaluations. She has contributed to narrative reviews on perioperative management of complex conditions and environmental sustainability in healthcare. Grants & Mentorship: As a leader in ambulatory anesthesia and women’s professional development in medicine, she advocates for mentorship programs and equitable representation in academic roles. Her clinical leadership drives enhanced recovery protocols and multimodal pain management strategies. Labs & Teams: Directs the Pre-Surgical Evaluation Center, fostering interdisciplinary collaboration to streamline preoperative evaluations and improve patient safety and environmental sustainability.
Mayo Clinic College of Medicine and ScienceUnited States
Christopher E. Colby, MD, is a physician scientist at Mayo Clinic's Department of Pediatrics and Critical Care in Rochester, Minnesota. With a medical degree from Medical College of Wisconsin and specialized training in neonatal-perinatal medicine at Stanford's Lucile Salter Packard Children's Hospital, he has dedicated his career to advancing neonatal care through clinical practice, education, and research. 2003: Fellow in Neonatal and Developmental Medicine 2013-2016: Director of Neonatal-Perinatal Medicine Fellowship 2018: Inpatient Medical Director, Mayo Clinic Children's Center His research focuses on neonatal resuscitation , teleneonatology , and quality improvement in NICUs . Key contributions include: Development of 3D-printed CPAP masks Telemedicine applications for newborn resuscitation Regionalized perinatal care optimization Scientific Awards: Multiple 'Teacher of the Year' awards 2020 Minnesota Monthly Top Neonatologist 2013 DPAM Education Leadership Award
